BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21039888)

  • 1. TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic purpura.
    Yu H; Liu Y; Han J; Yang Z; Sheng W; Dai H; Wang Y; Xia T; Hou M
    Eur J Haematol; 2011 Jan; 86(1):67-74. PubMed ID: 21039888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.
    Zhou Z; Li X; Li J; Su C; Zhuang L; Luo S; Zhang L
    J Clin Immunol; 2010 Nov; 30(6):814-22. PubMed ID: 20628793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to refractory immune thrombocytopenic purpura.
    Bussel JB
    Blood Rev; 2002 Mar; 16(1):31-6. PubMed ID: 11913991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF - an essential survival factor for B cells: Links to genesis of ITP and may be of therapeutic target.
    Yu HM; Liu YF; Hou M
    Med Hypotheses; 2008; 70(1):40-2. PubMed ID: 17592744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
    Kajihara M; Kato S; Okazaki Y; Kawakami Y; Ishii H; Ikeda Y; Kuwana M
    Hepatology; 2003 Jun; 37(6):1267-76. PubMed ID: 12774004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of BLyS/April in patients with acute idiopathic thrombocytopenic purpura].
    Wang GB; Li CR; Li CG; Wang Y; Yang J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):595-8. PubMed ID: 19175985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
    McFarland J
    Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.
    Andersson PO; Wadenvik H
    Expert Rev Mol Med; 2004 Nov; 6(24):1-17. PubMed ID: 15538954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells as a target for the therapy of immune thrombocytopenia.
    Fu J; Zhang A; Ju X
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):469-75. PubMed ID: 22387587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR7 promotes Th1 polarization in immune thrombocytopenia.
    Yang Q; Wang B; Yu H; Zhu Y; Wang X; Jiang H; Wang C; Peng J; Hou M
    Thromb Res; 2011 Sep; 128(3):237-42. PubMed ID: 21458848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of TLR7 and TLR9 in murine SLE.
    Santiago-Raber ML; Baudino L; Izui S
    J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
    Catani L; Fagioli ME; Tazzari PL; Ricci F; Curti A; Rovito M; Preda P; Chirumbolo G; Amabile M; Lemoli RM; Tura S; Conte R; Baccarani M; Vianelli N
    Exp Hematol; 2006 Jul; 34(7):879-87. PubMed ID: 16797415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of chronic immune thrombocytopenic purpura.
    Cines DB; McMillan R
    Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
    Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
    Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent topics on basic research for idiopathic thrombocytopenic purpura].
    Kuwana M; Kawakami Y; Ikeda Y
    Rinsho Byori; 2001 Oct; 49(10):992-5. PubMed ID: 11769478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathogenesis of primary immune thrombocytopenia].
    Gudbrandsdottir S; Frederiksen H; Birgens HS; Nielsen CH; Nielsen OJ; Stentoft J; Hasselbalch HC
    Ugeskr Laeger; 2011 Jan; 173(4):274-7. PubMed ID: 21262172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.
    Pérez-Simón JA; Tabera S; Sarasquete ME; Díez-Campelo M; Canchado J; Sánchez-Abarca LI; Blanco B; Alberca I; Herrero-Sánchez C; Cañizo C; San Miguel JF
    Cytotherapy; 2009; 11(6):698-705. PubMed ID: 19878056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
    Kuwana M; Kaburaki J; Ikeda Y
    J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.
    Emmerich F; Bal G; Barakat A; Milz J; Mühle C; Martinez-Gamboa L; Dörner T; Salama A
    Br J Haematol; 2007 Jan; 136(2):309-14. PubMed ID: 17156395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.